Capital Flow Monitor · Sponsors · CIK 1723907
RESTOR3D, Inc.
4001 E NC 54 HIGHWAY, DURHAM, NC, 27709 · 678-469-0395
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$94.8M
Sold
$84.8M
% sold
89.5%
Investors
133
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-08-22 | D ·current | 506(b) | $94.8M | $84.8M | 89.5% | 133 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Kurt Jacobus — Executive Officer / Director, Durham, NC
3 other raises
- Huxley Medical, Inc. $11.0M of $11.7M · 94.2%
- EarliTec Diagnostics, Inc. $3.5M of $7.0M · 50.0%
- Nanochon, Inc. $3.6M of $4.2M · 84.8%
-
Kenneth Gall — Executive Officer, Durham, NC
3 other raises
- Huxley Medical, Inc. $11.0M of $11.7M · 94.2%
- Orthobond Corp $8.3M of $10.0M · 83.5%
- Protect3d, Inc. $845K of $1.0M · 84.5%
- Andrew Miller — Executive Officer, Durham, NC
-
Cambre Kelly — Executive Officer, Durham, NC
1 other raise
- Reselute, Inc. $2.4M of $4.0M · 59.8%
- Greg Anglum — Executive Officer, Durham, NC
-
Michael Porter — Director, Durham, NC
1 other raise
- Huxley Medical, Inc. $11.0M of $11.7M · 94.2%
- Brian Neiswender — Director, Durham, NC
-
Andrew Summers — Director, Durham, NC
1 other raise
- Summers Value Fund LP $20.3M of —
-
Douglas Kohrs — Director, Durham, NC
2 other raises
- Osteal Therapeutics, Inc. $15.6M of $26.7M · 58.4%
- Vergent Bioscience, Inc. $18.7M of $32.0M · 58.4%
- Stuart E. Huston — Director, Durham, NC
- Erich Wolff — Director, Durham, NC
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.